The ethanolamine branch of the Kennedy pathway is essential in the bloodstream form of Trypanosoma brucei by Gibellini, Federica et al.
The ethanolamine branch of the Kennedy pathway is
essential in the bloodstream form of Trypanosoma bruceimmi_6764 826..843
Federica Gibellini,1 William N. Hunter1 and
Terry K. Smith2*
1Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, Dundee
DD1 5EH, Scotland, UK.
2Centre for Biomolecular Sciences, The North Haugh,
The University, St Andrews KY16 9ST, Scotland, UK.
Summary
Phosphatidylethanolamine(GPEtn),amajorphospho-
lipid component of trypanosome membranes, is syn-
thesized de novo from ethanolamine through the
Kennedy pathway. Here the composition of the GPEtn
molecular species in the bloodstream form of Trypa-
nosoma brucei is determined, along with new insights
into phospholipid metabolism, by in vitro and in vivo
characterization of a key enzyme of the Kennedy
pathway, the cytosolic ethanolamine-phosphate cyti-
dylyltransferase (TbECT) . Gene knockout indicates
that TbECT is essential for growth and survival, thus
highlighting the importance of the Kennedy pathway
for the pathogenic stage of the African trypanosome.
Phosphatiylserine decarboxylation, a potential
salvage pathway, does not appear to be active in cul-
tured bloodstream form T. brucei, and it is not upregu-
lated even when the Kennedy pathway is disrupted. In
vivo metabolic labelling and phospholipid composi-
tion analysis by ESI-MS/MS of the knockout cells con-
ﬁrmedasigniﬁcantdecreaseinGPEtnspecies,aswell
as changes in the relative abundance of other phos-
pholipid species. Reduction in GPEtn levels had a
profound inﬂuence on the morphology of the mutants
and it compromised mitochondrial structure and
function, as well as glycosylphosphatidylinositol
anchor biosynthesis. TbECT is therefore genetically
validated as a potential drug target against theAfrican
trypanosome.
Introducton
The unicellular eukaryote Trypanosoma brucei is the
cause of sleeping sickness in humans and Nagana in
livestock, in Sub-Saharan Africa. Current treatment
has limitations and efforts are being directed into the
assessment of drug targets and the development of new
drugs. Studies on T. brucei metabolism can unravel
novel and unique aspects of the parasite’s biology that
are not only of intrinsic interest and often directly appli-
cable to understanding the disease and to assist the
development of new therapies (van Hellemond and
Tielens, 2006).
One area with potential as a drug target is the de novo
biosynthesis of phospholipids (Ancelin and Vial, 1986;
Hernández-Alcoceba et al., 1997; Urbina, 2006; Choubey
et al., 2007; Jez, 2007). Phospholipids contribute an
important structural role to the membrane and their prop-
erties determine membrane ﬂuidity and cell surface
charge. They are implicated in a wide variety of cellular
processes, including cell division and cell signalling
(Dowhan, 1997). Ethanolamine derived phospholipids
(GPEtn, phosphatidylethanolamine), which include dia-
cylGPEtn, alkyl-acylGPEtn and alkenyl-acylGPEtn (plas-
malogen), can increase the tendency of membranes to
form non-bilayer structures, thus inﬂuencing membrane
fusion and trafficking (Dowhan, 1997; Bakovic et al.,
2007). These lipids affect the folding, stabilization and
activity of integral and membrane-bound proteins and in
certain cases GPEtn or GPEtn-derived ethanolamine-
phosphoglycerol can be attached to protein residues as a
post-translational modiﬁcation (Signorell et al., 2008a).
GPEtn is also the donor for the ethanolamine-phosphate
capping of the glycosylphosphatidylinositol (GPI) anchor
that is required for attachment of proteins to the outer
leaﬂet of the cell membrane (Menon and Stevens, 1992;
Menon et al., 1993; Imhof et al., 2000). This is particularly
important for the bloodstream form of T. brucei, which
relies on a dense coat of GPI-anchored variant surface
glycoprotein (VSG) to circumvent the attack of the host
immune system (Nagamune et al., 2000). Disruption of
GPEtn biosynthetic pathways in T. brucei is likely to
severely impair the parasite homeostasis and thus, the
constituent enzymes may represent novel targets for
chemotherapy.
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are the CDP-ethanolamine (CDP-Etn) pathway, also
called the Kennedy pathway, and the phosphatidylserine
(GPSer) decarboxylation pathway. The CDP-Etn pathway
consists of three enzymatic steps. Initially, ethanolamine
kinase (EK, EC 2.7.1.82) catalyses the ATP-depen-
dent phosphorylation of ethanolamine (Etn), forming
ethanolamine-phosphate (Etn-P), and the by-product
ADP. In stage two, the CTP:ethanolamine-phosphate cyti-
dylyltransferase (ECT, EC 2.7.7.14), the subject of this
study, utilizes Etn-P and CTP to form the high-energy
donor CDP-Etn with the release of pyrophosphate.
This reaction is considered to be the rate-limiting
step of the Kennedy pathway (Sundler and Akesson,
1975). Diacylglycerol: CDP-ethanolamine ethanolamine-
phosphotransferase (EPT, EC 2.7.8.1) catalyses the ﬁnal
reaction of the pathway, utilizing CDP-Etn and diacylglyc-
erol or alkyl-acylglycerol to form diacylGPEtn or plasmalo-
gen, respectively, with CMP as by-product.
An alternative route for the synthesis of GPEtn is the
decarboxylation of GPSer by a phosphatidylserine
decarboxylase (PSD). This pathway is actually the sole
route for GPEtn biosynthesis in Escherichia coli and the
major one in Saccharomyces cerevisiae, although in
yeast the Kennedy pathway is also active (Dowhan,
1997). In mammalian cells the relative contributions of
these pathways to GPEtn formation is cell-type depen-
dent, with GPSer decarboxylation prevailing in BHK21
and CHO cells and the Kennedy pathway prevailing in
most mammalian tissues (hamster heart, rat heart,
kidney and liver), and cultured glioma cells (Vance,
2008).
Metabolic labelling and pulse-chase experiments pro-
vided some evidence that in T. brucei GPEtn could be
made from either ethanolamine or serine, even though the
Kennedy pathway is used for most of the GPEtn biosyn-
thesis (Rifkin et al., 1995). This was recently conﬁrmed by
RNAinterference in the insect form of the parasite (Signo-
rell et al., 2008a,b), but until now, no detailed studies were
performed in bloodstream T. brucei. We show, for the ﬁrst
time, that the putative T. brucei CTP:ethanolamine-
phosphate cytidylyltransferase (TbECT) gene (Tb11.
01.5730) encodes a functional enzyme, and we charac-
terize the enzyme activity and substrate requirements.
Formation of a bloodstream form T. brucei TbECT condi-
tional double knockout (cKO) allowed us to demonstrate
that TbECT is essential and under non-permissive condi-
tions the synthesis of GPEtn and GPI-anchors is severely
compromised. We also show that GPSer decarboxylation
makes a very minor contribution to bulk GPEtn biosynthe-
sis and it cannot compensate for the loss of the Kennedy
pathway in the TbECT cKO. These ﬁndings suggest there
may be therapeutic opportunities in targeting the Kennedy
pathway.
Results and discussion
Contributions of the Kennedy pathway and GPSer
decarboxylation pathway to GPEtn biosynthesis in
bloodstream form T. brucei
The relative contribution of the GPSer decarboxylation
pathway to GPEtn biosynthesis was assessed by stable
isotope labelling with d3-serine in normal culturing media
overnight, in order to allow adequate time for phospholipid
synthesis and a dynamic equilibrium between phospho-
lipids pools to be reached. Subsequent analysis of the
phospholipid molecular species by electrospray ionization
tandem mass spectrometry (ESI-MS/MS) allowed the
overall contribution of the GPSer decarboxylation
pathway to GPEtn biosynthesis to be assessed. Upon
labelling the d3-serine is readily incorporated into newly
synthesized d3-GPSer, which is virtually super imposable
with the pre-existing unlabelled GPSer visualized by
neutral loss scans of m/z 89 and 87 respectively (compare
Fig. 1A and B).
Similarly, the newly synthesized d3-GPEtn formed by
GPSer decarboxylation of newly synthesized d3-GPSer
detected by a parent ion scan analysis for lipids that
produce the collison induced 199 m/z fragment in nega-
tive ion mode, as opposed to the bulk GPEtn visualized
with the collision induced 196 m/z fragment ion (compare
Fig. 1C and D). Table S1 shows the annotation of the
GPEtn molecular species identiﬁed in bloodstream form
T. brucei.
Although previous work (Rifkin et al., 1995) seemed to
indicate that bloodstream form T. brucei was able to syn-
thesize GPEtn from GPSer via decarboxylation, our
experiment clearly shows only trace amounts of d3-GPEtn
(Fig. 1D), which differ signiﬁcantly from the de novo syn-
thesized GPEtn via the Kennedy pathway (Fig. 1C). This
suggests that GPSer decarboxylation contributes little to
the biosynthesis of GPEtn under these conditions and it
conﬁrms the importance of the Kennedy pathway in the
biosynthesis of GPEtn in bloodstream T. brucei.
Identiﬁcation, cloning and sequencing of TbECT
The genome sequence of T. brucei (Berriman et al., 2005)
is an invaluable resource for the understanding of the
molecular and cellular biology of this important parasite.A
putative TbECT (Tb11.01.5730) was identiﬁed in the
T. brucei genome database (http://www.genedb.org); the
putative open reading frame (ORF) was PCR-ampliﬁed
from genomic DNA (Lister 427), cloned and the sequence
submitted to GenBank Nucleotide Sequence Database
with Accession number FM992871. The complete ORF
encodes for a protein of 384 residues with a calculated
molecular mass of 43.4 kDa.Although TbECT shows con-
siderable similarity to ECTs from mammalian organisms
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unsurprisingly most closely related to putative ECTs from
other kinetoplastids such as Leishmania major and
T. cruzi, with 59% and 62% sequence identity respectively
(Fig. 2A and B). Like previously characterized ECTs,
TbECT contains two large tandem repeated sequences,
probably a result of gene duplication (Nakashima et al.,
1997; Bladergroen et al., 1999). The N-terminal repeat is
strongly conserved amongst ECTs and other members of
the cytidylyltransferase family: glycerol-3-phosphate cyti-
dylyltransferases (GCT) and the N-terminal domain of
choline-phosphate cytidylyltransferases (CCT).
All the signature motifs that characterize the cytidylyl-
transferase family are present in the TbECT sequence:
two conserved GX(Y/F)DXXHXGH sequences, contain-
ing the HXGH motive (47HFGH and 227HAGH, Fig. 2A,
boxed) with the adjacent Asp44 and Asp224 (Fig. 2A,
asterisks); one RTX(G/C/S)ISTT motif (152RTECISTT)
(Fig. 2A, underlined); and the two regions 96KWVDAVI
and 278RYVDDVV (Fig. 2A, double underlined). The struc-
ture of Bacillus subtilis GCT (Weber et al., 1999; Pattridge
et al., 2003) revealed that the HXGH motif and the
RTX(G/C/S)ISTT motif are involved in the formation of the
CTP binding site, whereas the third motif is involved in the
formation of a dimer interface.
Recombinant expression and characterization of TbECT
To establish if TbECT is an active ethanolamine-
phosphate cytidylyltransferase and to obtain material for
the characterization of its properties, TbECT was cloned
in the expression vector pET20bTEV. This vector encodes
for a hexa-histidine tag at the C-terminal of the protein,
which can be removed by proteolytic cleavage with
Tobacco Etch Virus (TEV) protease (Fig. S1A). The
protein was expressed and puriﬁed as described in
Experimental procedures. Typical yields were 20–25 mg
per litre of culture. TbECT could be stored at -80°C in
buffer containing 5% glycerol without loss of activity over
a period of months.
Matrix-assisted laser desorption/ionization (MALDI)
mass spectrum of the cleaved recombinant TbECT
returned a molecular mass of 44 623 Da (theoretical
value predicted for recombinant TbECT: 44 622 Da).
Analytical ultracentrifugation was performed on
untagged TbECT. The sample displayed a single species
of mass ~52 kDa, which agrees with the theoretical mass
of the monomer (Fig. S1B).
Interestingly, the rat and human ECTs, with which
TbECT shares high sequence identity, form dimers or
higher aggregates in solution (Sundler, 1975; Tie and
Bakovic, 2007). The only other reported monomeric ECT
is from S. cerevisiae (Ohtsuka et al., 2006), which shares
34% sequence identity with TbECT (Fig. 2), despite both
of these homologues having the sequence motif predicted
to play a role at the dimer interface.
TbECT catalysed the formation of CDP-ethanolamine
from ethanolamine-phosphate, in a CTP and magnesium-
dependent manner (Fig. S2). At the pH optimum of 7.5
(Fig. 3A) TbECT displays a Km of 12.09  0.87 mM
(Fig. 3B) for ethanolamine-phosphate and a Kmo f
12.67  0.78 mM (Fig. 3C) for CTP. These values
Fig. 1. ESI-MS/MS spectra of the following molecular species: GPSer (A); (d3)-GPSer (B); GPEtn (C) and (d3)-GPEtn (D) in bloodstream
T. brucei labelled with (d3)-serine overnight. Data were normalized to largest peak on display and vertical axes linked in order to directly
compare the intensities of non-deuterated versus deuterated phospholipid species.
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terized ECTs from rat (KmCTP = 53 mM; KmETN-P = 65 mM
(Sundler, 1975) and are about one order of magnitude
lower than the corresponding Kms in mouse (Tie and
Bakovic, 2007). Particularly striking is the unusually
low Km for the cofactor CTP; this may reﬂect the relatively
low intracellular concentration of this nucleotide triphos-
phate in T. brucei (Hofer et al., 1998) compared with
the pool present in mammalian cells (Stryer, 1995;
Lazarowski and Boucher, 2001) The Vmax of TbECT is
1.55  0.03 mmol min-1 mg-1, corresponding to a kcat of
1.15 s-1.
TbECT activity was found to be selective for CTP, since
no activity was detected withATP, GTP or UTP (Table S2).
The enzyme, however, was able to utilize dCTP, although
at a reduced rate, implying that the enzyme is able to
discriminate between a deoxyribonucleotide and a ribo-
nucleotide moiety. This is consistent with trace amounts of
dCDP-ethanolamine being found in bloodstream form
T. brucei (Rifkin et al., 1995).
Interestingly, TbECT was unable to accept 2-aminoethyl
phosphonate (AEP) as a substrate. AEP is an essential
metabolite for the formation of phosphonolipids, which
carry a covalent bond between the phosphorous and the
carbon of the nitrogenous base (Baer and Stanacev,
1964). However, previous studies (Ferguson et al., 1982)
failed to detect any phosphonolipids in T. brucei, unlike
the closely related trypanosomatid, T.cruzi, this is
Fig. 2. A. ClustalW alignment of the predicted amino acid sequences of Trypanosoma brucei ECT (Q382C3-1) with ethanolamine
cytidylyltransferases and glycerol-3-phosphate cytidylyltransferases from other eukaryotes: Leishmania major (Q4Q5J3), Trypanosoma cruzi
(Q922E4), Homo sapiens (Q99447), Saccharomyces cerevisiae (P33412) ECTs and Bacillus subtilis GCT. Residues are shaded according to
percentage identity using the software Jalview 2.08.1. Boxed and underlined regions are characterisitic signature motif of cytidylyltransferases.
B. Phylogenetic analysis of ECTs and GCTs from Fig. 2A plus ECTs from Mus musculus (Q922E4), Rattus norvegicus (O88637),
Chlamydomonas reinhardtii (Q84JV7) and Arabidopsis thaliana (Q9ZVI9).
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thesis of AEP in T. brucei (Sarkar et al., 2003) and, as
shown here, in the substrate speciﬁcity of TbECT.
Construction of a TbECT conditional null mutant
To assess the importance of TbECT and therefore of the
entire Kennedy pathway for the survival of bloodstream
form T. brucei, a conditional null knockout was generated
and characterized.
Preliminary analysis showed that the TbECT gene was
present as a single copy per haploid genome and
expressed in both bloodstream form and insect life cycle
stages (Fig. S3). A conventional mutagenesis approach
(Martin and Smith, 2006a) was followed: one allele was
replaced by the puromycin resistance gene (PAC) gener-
ating the DECT::PAC cell line; a haemagglutinin (HA)-
tagged tetracycline-inducible ectopic copy of the gene was
introduced into the ribosomal DNA, yielding the cell line
ECT-HA Ti DECT::PAC; while maintaining the expression of
the ectopic copy by addition of tetracycline, the remaining
allele was replaced by a hygromycin resistance gene
resulting in the conditional double knockout cell line ECT-
HA Ti DECT::PAC/DECT::HYG. The genotype of the condi-
tional null mutant was veriﬁed by Southern blot analysis,
where only the ectopic copy is present (Fig. 4A, lane 3).
TbECT is essential to T. brucei bloodstream form
To establish whether ECT was an essential gene, the cell
line ECT-HA Ti DECT::PAC/DECT::HYG was cultured in the
presence or absence of tetracycline and growth rates
compared with wild-type. Triplicate cultures for every cell
type were inoculated at 1 ¥ 105 cells ml-1 and subcultured
every two days when necessary. In the presence of tetra-
cycline, that is, in permissive conditions that allow expres-
sion of ECT-HA Ti, cells showed normal growth kinetics,
comparable to wild-type cells (Fig. 4B). However, when
cultured in tetracycline-free media (non-permissive condi-
tions), cells immediately displayed a reduced growth rate
and after 48 h they had only attained approximately half
the cell density of the wild-type (Fig. 4B). After 72 h an
increasing amount of cell debris could be observed and by
day 4 cell numbers fell below the limit of detection by light
microscopy. RT-PCR conﬁrmed TbECT mRNAdisappear-
ance after 24 h in non-permissive conditions (Fig. 4C).
However, 7–8 days after tetracycline removal live cells
were again visible and normal growth rates were
resumed. This resumption of growth was due to revertant
cells overcoming the tetracycline control, as demon-
strated by the reappearance of TbECT mRNA in these
cells (Fig. 4C). This phenomenon, described many times
before in T. brucei conditional null mutants for essential
genes (Martin and Smith, 2006a), is mostly ascribed to
Fig. 3. Analysis of CDP-ethanolamine formation by recombinant
TbECT.
A. Ethanolamine-phosphate cytidylyltransferase activity was
determined by end-point assay as a function of pH as described in
Experimental procedures.
B and C. Determination of TbECT Michaelis-Menten constants for
ethanolamine-phosphate and CTP (inserts show Lineweaver–Burk
plots). (B) CTP concentration was held constant (0.1 mM) while
ethanolamine-phosphate concentration was varied. (C)
Ethanolamine-phosphate concentration was held constant (0.1 mM)
while CTP concentration was varied.
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et al., 2002).
TbECT deprivation affects cellular dimensions and
subcellular architecture
Scanning electron micrographs of TbECT cKO cells
deprived of tetracycline for 36 h suggested a reduction in
overall cellular dimensions (almost ‘stumpy-like’) when
compared with control cells (Fig. S4A, compare panels 1
and 2 with 3 and 4). Determination of the average cell
volume (CASY cell counter, SEDNA Scientiﬁc) conﬁrmed
an average reduction of up to 30% of cell volume after
48 h of growth in tetracycline free media (Fig. S4B).
Transmission electron microscopy was used to investi-
gate the subcellular architecture of TbECT cKO cells at
Fig. 4. TbECT is essential for the survival of
bloodstream form Trypanosoma brucei in
culture.
A. Conﬁrmation of genotype of T. brucei ECT
conditional double knockout cell line.
Southern-blot analysis of NcoI-digested
genomic DNA (5 mg); the ECT ORF probe
shows allelic TbECT at 4.4 kb and the ectopic
copy TbECT-HATi at ~5 kb 1; parental cells
(SM) 2; DECT::PAC/ECT-HA
Ti 3;
DECT::PAC/DECT::HYG/ECT-HA
Ti 4;
Undigested DNA.
B. Growth curves of T. brucei parental cells (1
– ﬁlled circles) and TbECT conditional
knockout cells grown in the presence (2 –
empty circles) or absence (3 – ﬁlled triangles)
of tetracycline.
C. RT-PCR ampliﬁcation of TbECT RNA
transcripts from total RNA extracted from
TbECT conditional null mutants grown in the
absence of tetracycline for 0, 12, 24, 36 and
48 h. The upper panel shows RT-PCR
products using primers speciﬁc for TbECT;
the middle panel shows a PCR-negative
control, without reverse transcriptase; the
lower panel shows a loading control using
tubulin tyrosine-ligase (TbTTL) primers.
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Fig. 5A (panels b–e) the main morphological defect
appears to be an abnormally enlarged mitochondria,
which is usually a thin and narrow tubular structure in the
SM parental cells (Fig. 5A, panel a). This abnormal
enlargement of the mitochondria was quantiﬁed in over 60
suitable transmission electron micrographs at relevant
time points. At 36 h without tetracycline ~70% of the
examined mitochondria were signiﬁcantly enlarged, which
increased to ~90% at 42 h (Fig. 5A, panel f).
To investigate whether this enlargement reﬂects a loss
of function of the organelle, trypanosomes were stained
with the membrane potential-dependent ﬂuorescent dye
Mitotracker Red (Fig. 5B) and observed by ﬂuorescence
microscopy. TbECT cKO trypanosomes grown under non-
permissive conditions for 36 h still show an accumulation
of the dye in the mitochondria, even though the volume of
the organelle appears to be increased (Fig. 5B, lane c),
suggesting that even if enlarged, the mitochondria is still
able to maintain its membrane electrostatic potential.
However, after 42 h from tetracycline removal, the dye
signal almost completely disappears, suggesting loss of
function (Fig. 5B, lane d). Changes in mitochondrial mor-
phology and function have been observed before in mam-
malian PSD mutants (Steenbergen et al., 2005) and in
T. brucei procyclic ACP mutants as a result of a decrease
of GPEtn in this organelle (Guler et al., 2008).
Phenotype analysis of TbECT conditional null mutants
by in vivo labelling
The biochemical phenotype of the conditional double
knockout cells was investigated by in vivo labelling with
either [3H]Etn, [3H]Ser, [3H]Man or [3H]Myr (Fig. 6) to
ascertain the effect of TbECT disappearance on GPEtn
biosynthesis and potential knock-on effects to GPI anchor
biosynthesis and general phospholipid metabolism. The
results show a clear decrease of GPEtn formed through
the Kennedy pathway in the cKO under non-permissive
conditions (Fig. 6A, compare lanes 1–3). This GPEtn
decrease does not prompt an upregulation of the GPSer
decarboxylation pathway, since no GPEtn is observed
from the newly synthesized GPSer (Fig. 6A, lanes 4–6).
This represents a fundamental difference with the behav-
iour of mammalian cells in culture: the Kennedy pathway
is the favoured pathway for the biosynthesis of GPEtn
when ethanolamine is readily available in the culture
media, but the GPSer decarboxylation pathway can com-
pensate under conditions of ethanolamine deprivation
(Voelker, 1984).
As expected, blocking the Kennedy pathway at the ECT
level results in the disappearance of the CDP-Etn product
(Fig. 6C, lane 3). Surprisingly though, this does not trans-
late into an accumulation of the substrate Etn-P (Fig. 6C,
lane 3); this could be due to either a downregulation of
EK1 or to channelling of the excess of Etn-P into other
catabolic or metabolic pathways. This also means that the
phenotypical effects of the ECT knockout are due to the
disappearance of CDP-Etn and the downstream metabo-
lites, i.e. GPEtn, rather than due to an accumulation of
toxic levels of Etn-P.
Since GPEtn is the donor of the terminal phospho-
ethanolamine group of GPI anchors (Menon et al., 1993;
Imhof et al., 2000), whose biosynthesis has been previ-
ously validated as a drug target in the African trypano-
some, we tested the possibility that a reduction in cellular
GPEtn could produce a knock-on effect on the GPI
pathway.
An [3H]Man labelling of parental cells and of TbECT
cKO cells grown in permissive conditions highlighted the
formation of the expected mature GPI anchor glycolipids
A and C (Fig. 6A, lanes 7 and 8) as previously reported
(Martin and Smith, 2006b). However, the conditional
double knockout cells grown in non-permissive conditions
for 36 h displayed a marked decrease in the amount of
those labelled species (Fig. 6A, lane 9), meaning that the
decrease in GPEtn synthesis, due to deletion of TbECT,
has a detrimental effect on the biosynthesis of mature GPI
anchors.
In addition, the [3H]Myr labelling shows that there is a
slight decrease in the amount of phospholipids synthe-
sized by the conditional double null cells grown in non-
permissive conditions for 36 h (Fig. 6A, compare lanes
10–12).
To conﬁrm that the cells were still viable at the time of
labelling, their ability of the cells to perform normal rates of
protein synthesis was conﬁrmed. The wild-type cells and
the conditional double null cells grown in the presence or
absence of tetracycline for 36 h showed similar amounts
of [35S]methionine incorporation into newly synthesized
proteins (Fig. 6B), meaning that the biochemical changes
detected by the in vivo labelling experiments are a con-
sequence of TbECT deprivation and not due to a general
loss of viability. We note that at 48 h, protein synthesis has
been partially compromised (data not shown), thus 36 h
was chosen for biochemical phenotyping.
Lipid proﬁle of TbECT conditional null mutants by
ESI-MS/MS
To ascertain if the decrease in GPEtn is due to a decrease
in particular GPEtn species or to a global decrease of
GPEtn species, and whether this affected the composition
of other phospholipid classes, whole-cell extracts from the
TbECT cKO cell line grown in the presence or absence of
tetracycline for 36 h were semi-quantitatively analysed by
ESI-MS/MS and compared with wild-type (Figs 7 and 8
and Figs S5–8). The negative and positive ion survey
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B
Fig. 5. Loss of ECT activity affects mitochondrial morphology and function.
A. Transmission electron micrographs of TbECT cKO cells taken before (a) and after 36 (b) or 42 h (c–e) of tetracycline removal from the
media. (f) Quantiﬁcation of sections displaying an abnormal enlargement of the mitochondria in wild-type and in TbECT cKO cells at different
time points after tetracycline removal (SM parental cell, n = 43; TbECT cKO + Tet, n = 83; TbECT cKO + Tet, n = 65; TbECT cKO -Tet42 h,
n = 68). Scale bar = 2 mm.
B. Mitotracker red CMXRos was used to stain live cells prior to ﬁxation (3); cells were then counterstained in DAPI (2); the corresponding
phase contrast images are shown in (1), whereas merged ﬂuorescence-phase images are shown in (4). Mitotracker ﬂuorescence images were
collected with the same acquisition time of 542 ms to allow the data to be examined for differences in ﬂuorescence intensity. (a), SM parental
cells; (b) TbECT cKO cells grown in the presence of tetracycline; TbECT cKO cells grown in the absence of tetracycline for 36 h (c) or
42 h (d).
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conditions contain substantial differences from the control
ones, as highlighted by the asterisks (Fig. S5A and B).
A more detailed investigation of the individual phospho-
lipid classes was conducted by parent ion and neutral loss
scanning of speciﬁc collision induced fragment ions char-
acteristicforeachphospholipidsclass.Initiallytheeffecton
GPEtn was investigated. Figure 7 shows that the major
GPEtn peak encompassing molecular species in the mass
range m/z 724–732 (e-36:3 – a-36:0, Table S1) was con-
siderablyreducedintheTbECTcKOgrownintheabsence
of tetracycline for 36 h, compared to either the parental
cells or the TbECT cKO grown in the presence of tetracy-
cline (Fig. 7, compare A and B with C). The principal
Fig. 6. Phenotype analysis of the TbECT conditional knockout by in vivo labelling.
A. SM parental cells (lanes 1, 4, 7 and 10); TbECT cKO cells grown in the presence (lanes 2, 5, 8 and 11) or absence of tetracycline for 36 h
(lanes 3, 6, 9 and 12) were labelled with either [
3H]ethanolamine ([
3H]Etn, lanes 1–3), [
3H]serine ([
3H]Ser, lanes 4–6), [
3H]mannose ([
3H]Man,
lanes 7–9) and [
3H]myristate ([
3H]Myr, 10–12), lipids were extracted, desalted and run on HPTLC as described in Experimental procedures.
Incorporation of radiolabel into lipids was detected by ﬂuorography. Lipid standards of GPEtn, lysoGPEtn and GPSer are indicated on the left.
Glycolipids A and C are indicated on the right.
B. Cells were labelled with [35S]methionine and proteins extracted and separated on a 4–10% SDS-PAGE gel. Proteins were then detected
by Coomassie Blue staining (lanes 1–3) or by ﬂuorography (lanes 4–6). Lanes 1 and 4, SM parental cells; lanes 2 and 5, TbECT cKO cells
grown in the presence of tetracycline; lanes 3 and 6, TbECT cKO cells grown in the absence of tetracycline for 36 h.
C. The water-soluble metabolites of the Kennedy pathway were extracted from cells labelled with [
3H]Etn and run on HPTLC. The metabolites
Etn, Etn-P and CDP-Etn are indicated on the right.
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GPEtn (e-18:0/18:2) by daughter ion scanning of m/z 726
(Fig. 7D). The relative ratio of the intensity of the GPEtn
(e-18:0/18:2) peak at m/z 726 with that of the internal
standard GPEtn (15:0/15:0), was used to compare the
amount of GPEtn in the different samples and showed that
the amount of plasmalogen GPEtn after only 36 h of ECT
deprivation is reduced to less than a third of the amount
contained in the parental cells and the TbECT cKO grown
in the presence of tetracycline.
Parallel to this GPEtn reduction there is a correspond-
ing increase in the phosphatidylcholine (GPCho) peak at
m/z 768–776 that includes phospholipids that carry the
same kind of fatty acyl constituents (e-36:3 – a-36:0)
(Fig. 8, compare A and B with C), with the major species
identiﬁed by daughter ion scanning as GPCho (a-18:0/
18:2) (Fig. 8D). This phenomenon can be attributed to the
alkyl-acyl-glycerol not being utilized by EPT in the last
step of the Kennedy pathway for lack of CDP-Etn, and
thus the excess lipid/substrate is being channelled to the
formation of ether GPCho phospholipids through the
CDP-choline branch of the Kennedy pathway. Whereas
the GPEtn (a-18:0/18:2) species would normally proceed
to the formation of the plasmalogen form GPEtn (e-18:0/
18:2), the GPCho (a-18:0/18:2) remains in the alkyl-acyl
form.
In addition, the cKO cells grown in the absence of
tetracycline for 36 h show an increase in both phospha-
tidic acid (GPA) and phosphatidylglycerol (GPGro) peaks
at m/z 749 and 773 respectively (Fig. S6), as assessed by
parent ion scanning in negative ion mode of glycerol-
cyclic phosphate collision induced ion at m/z 153. These
Fig. 7. GPEtn phospholipid analysis by ESI-MS/MS. Ethanolamine-containing phospholipids were analysed by ESI-MS/MS in negative ion
mode using parent-ion scanning of the collision induced fragment m/z 196. The arrows indicate the peaks of internal standard GPEtn
(15:0/15:0), which was subjected to ninefold magniﬁcation for clarity.
A. SM parental cells.
B. TbECT cKO cells grown in the presence of tetracycline.
C. TbECT cKO cells grown in the absence of tetracycline for 36 h.
D. Daughter ion spectrum of the m/z 726 [M-H]
- ion.
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(18:0/18:2) by daughter ion ES/MS-MS (Fig. S6D and E).
Since the increase in GPGro (18:0/18:2, m/z 773) is mir-
rored in the cKO cells grown in the presence of tetracy-
cline, we can hypothesize that the increase in these
phospholipid species is a result of the trypanosome
metabolism attempting to compensate for a suboptimal
amount of GPEtn and/or overall from unused lipid accep-
tor for GPEtn via EPT.
Interestingly, the total amount and composition proﬁle of
both GPSer and phosphatidylinositol (GPIno) are not
altered signiﬁcantly in the cKO in the absence of tetracy-
cline (Figs S7 and S8 respectively). This correlates with
the observation that GPSer biosynthesis is only margin-
ally affected by a reduction in GPEtn levels (Fig. 6, lanes
4–6) and seems to exclude the possibility that in blood-
stream form T. brucei GPSer is synthesized by a base-
exchange reaction with GPEtn, a pathway which seems to
be present in the procyclic form of the parasite (Signorell
et al., 2008b).
ECT depletion has a knock-on effect on the GPI anchor
biosynthetic pathway
The effect of GPEtn deprivation on the GPI-anchor bio-
synthetic pathway was studied in more detail by using a
trypanosomal cell-free system, an in vitro assay in which
the throughput through the GPI pathway is maximized
(Smith et al., 1996). Washed membranes were incubated
with GDP-[3H]Man and UDP-GlcNAc in the presence of
dithiothreitol (DTT) (Fig. 9, lane 2), leading to the forma-
tion of dolichol-phosphate-[3H]mannose (DPM) and
Fig. 8. GPCho and sphingomylein phospholipid analysis by ESI-MS/MS.
A–C. Choline-containing phospholipids were analysed by ESI-MS/MS in positive ion mode using parent-ion scanning of the collision induced
fragment phosphoryl-choline at m/z 184. The arrows indicate the peaks of internal standard GPCho (21:0/21:0). (A) SM parental cells; (B)
TbECT cKO cells grown in the presence of tetracycline; (C) TbECT cKO cells grown in the absence of tetracycline for 36 h.
D. Daughter ion spectrum of the m/z 773 [M + H]
+ ion.
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Man1GlcN-PI (M1), Man2GlcN-PI (M2), Man3GlcN-PI
(M3), Man3GlcN-(acyl)-PI(aM3), EtN-P-Man3GlcN-PI (A′)
and the sn-2 lyso species of A′ (Q).
Upon prolonged absence of tetracycline, i.e. 42 h, the
formation of the GPI intermediates downstream of the
Etn-P addition (glycolipidA′ and Q) is greatly reduced, and
it is paralleled by an increase in the GPI intermediate
upstream of the reaction (aM3; Fig. 9, lane 4). This dem-
onstrates that GPEtn deprivation has a very speciﬁc effect
on the GPI pathway, causing its arrest at the level of Etn-P
addition.
As a positive control of a GPI pathway stalled at the
level of Etn-P addition, the cell-free system was pre-
incubated with phenylmethanesulphonyl ﬂuoride (PMSF),
which inhibits the acylation of GPI intermediates (Fig. 9,
lane 1), preventing the addition of the Etn-P (Guther et al.,
1994).
TbECT is localized in the cytosol
Since optimal TbECT activity occurs at neutral pH
(Fig. 4A) and no signal peptides can be identiﬁed in the
amino acid sequence, a cytosolic localization of the
enzyme was hypothesized. The intracellular location was
assessed by taking advantage of the HA tag present at
the C-terminus of the ectopic copy in the cell line ECT-
HA Ti DECT::PAC/DECT::HYG cultured in the presence of
tetracycline. Detection was achieved by immunoﬂuores-
cence using a primary antibody against the HA-tag and a
ﬂuorescein 5′-isothiocyanate (FITC)-conjugated second-
ary antibody and, as expected, a cytosolic localization
was observed (Fig. 10A). This was conﬁrmed by Western
blot analysis of subcellular fractions probed with the
anti-HA antibody (Fig. 10B).
Cytosolic localization of ECT in T. brucei is shared with
mammaliancells(Vermeulenet al.,1993;Bleijerveldet al.,
2004);however,itdiffersconsiderablyfromthelocalization
of the enzyme in plants and algae, where studies on
Ricinus communis endosperm, Arabidopsis thaliana and
Chlamydomonasreinhardtiirevealamitochondrial(orperi-
mitochondrial) and ER localization (Mizoi et al., 2006;
Wang and Moore, 1991; Yang et al., 2004).
Conclusions
We have here demonstrated that the Kennedy pathway is
the sole relevant route for GPEtn biosynthesis in the
bloodstream form of T. brucei and is required for its
survival.
We highlighted differences with the behaviour of mam-
malian cells in culture in which an alternative pathway,
GPSer decarboxylation, can compensate for the loss of
the Kennedy pathway due to deprivation of the precursor
ethanolamine from the culture media (Voelker, 1984); in
bloodstream T. brucei the GPSer decarboxylation route
appears insigniﬁcant in the biosynthesis of GPEtn and is
unable to compensate for the loss of the Kennedy
pathway when this has been disrupted via TbECT gene
knockout.
This work also suggested an intriguing difference in the
phospholipid metabolism of the two main life cycle stages
of theAfrican trypanosome. In the procyclic form GPSer is
generated via base-exchange reaction with GPEtn and
downregulation of the Kennedy pathway completely
blocked GPSer synthesis (Signorell et al., 2008a).
However, we show that when the Kennedy pathway was
disrupted in the bloodstream form of T. brucei, GPSer
biosynthesis still occurred at levels comparable to the
wild-type. Therefore, in this life cycle stage GPSer biosyn-
thesis is more likely to proceed by coupling of serine to
CDP-DAG and this represents a major difference in the
phospholipid metabolism of the two life cycle stages.
The lethality of the TbECT cKO under non-permissive
conditions also shows that the corresponding cytidylyl-
transferase involved in the choline branch of the Kennedy
pathway is unable to compensate for the loss of the etha-
nolamine branch. The generation of a TbECT cKO cell
line allowed the assessment of the phenotypic changes
due to GPEtn deprivation. We showed that the morphol-
ogy of the mutants and of the mitochondrion was affected
at an early stage and later mitochondrial function was
disrupted. GPI anchor biosynthesis was also affected and
blocked at the level of the Etn-P addition, for which GPEtn
is the donor substrate.
Fig. 9. Effects of GPEtn deprivation on GPI intermediates
formation. T. brucei cell-free system of SM parental cells (lanes 1
and 2), TbECT cKO cells grown in the presence (lane 3) or
absence of tetracycline for 36 (lane 4) and 42 h (lane 5) were
labelled with GDP-[
3H]mannose in the presence or absence of
phenylmethanesulphonyl ﬂuoride, as indicated.
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stasis has the potential of interfering with numerous cel-
lular processes and structures, which explains the relative
rapidity of cell death and makes TbECT an attractive drug
target.
Furthermore, the characterization of the enzymatic
properties of ECT provided invaluable information for
future experiments aimed at developing inhibitors and
new therapeutic agents against the African trypanosome.
Experimental procedures
Reagents
Chemicals were purchased from Sigma-Aldrich or Fluka.
Restriction endonucleases and DNA modifying enzymes
were from New England Biolabs or Promega. [2-
3H] ethano-
lamine (50 Ci mmol
-1) and D-[2-
3H] mannose (15 Ci mmol
-1)
were purchased from Amersham. [9,10–
3H(N)]- tetrade-
canoic acid (myristic acid) (47 Ci mmol
-1) was from Perkin
Elmer, while L-[3–
3H]-serine (20 Ci mmol
-1) and GDP-
[
3H]mannose (20 Ci mmol
-1) were from ARC. L-[
35S] methion-
ine (1175 Ci mmol
-1) was from MP Biochemicals. L-[2,2,3–
2H]-serine (d3-Ser) was from CDN Isotopes.
The non-natural phospholipids standards 1,2-
diheptadecanoyl-sn-glycero-3-phosphate, GPA(17:0/17:0);
1,2-dipentadecanoyl-sn-glycerol-3-phosphoethanolamine
GPEtn(15:0/15:0); 1,2-dimyristoyl-sn-glycero-3-[phospho-
rac-(1-glycerol)], GPGro(14:0/14:0); 1,2-diheneicosanoyl-sn-
glycero-3-phosphocholine, GPCho(21:0/21:0); 1,2-
dimyristoyl-sn- glycerol-3-[phospho-L-serine], GPSer(14:0/
14:0); and 1-dodecanoyl-2-tridecanoyl- sn-glycero-3-
phospho-(1′-myo-inositol), GPIno(12:0/13:0) were purchased
from Avanti Polar Lipids.
Cloning and sequencing of T. brucei ECT
The putative TbECT gene was ampliﬁed from T. brucei strain
427 genomic DNA together with the 5′-and 3′ untranslated
regions (UTRs) of 278 and 402 bp, respectively, using Pfu
DNA polymerase and the forward and reverse primers
5′-ATAAGTAAgcggccgcGCTAAAGGTGTTGGTGAAACTAG
CGC-3′ (F1) and 5′-ATAAGTAAgcggccgcTGGTGAAAC
AAAACGTTAGTACA-3′ (R2) each containing a NotI restric-
tion site (lower case). The resulting 1.8 kb (ECT and UTRs)
fragment was cloned into pCR-Blunt-II TOPO vector (Invitro-
gen) yielding the pCR-Blunt-II-ﬂECT construct. Clones were
sequenced and compared with the annotated Gene Data
Bank sequences.
T. brucei cell culture
Bloodstream form T. brucei brucei strain Lister 427, previ-
ously genetically modiﬁed to express T7 polymerase and the
Fig. 10. Subcellular localization of ECT-HA in bloodstream form T. brucei cells.
A. Cells expressing ECT-HA were costained for the HA epitope and for the nuclear marker DAPI. (1) Phase contrast image. (2) DAPI staining.
(3) HA epitope staining and FITC detection. (4) Merged image.
B. Western blot analysis of subcellular fractions of cells expressing ECT-HA from differential centrifugation. Lane 1, microsomal fraction; lane
2, large granular fraction; lane 3, cytosolic fraction.
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to here as wild-type. This cell line allows inducible expression
of ectopic genes under the control of the T7 promoter and
tetracycline operator. Cells were cultured at 37°C and 5%
CO2 in HMI-9 medium supplemented with 2.5 mgm l
-1 of G418
to maintain the neomycin drug pressure. TbECT conditional
null mutant culturing media was supplemented with puromy-
cin, phleomycin, hygromycyn and tetracycline at the concen-
trations in the section below. Cells were counted daily and the
average cell volume recorded with a CASY Cell Counter and
Analyser System Model TT using lower and upper cell dimen-
sion limits of 2.40 and 5.70 mm.
Stable isotope labelling of bloodstream form T. brucei
2.5 ¥ 10
7T. brucei bloodstream form cells at a density of
0.5 ¥ 10
6 cells ml
-1 were incubated overnight at 37°C in
HMI-9 media supplemented with 1 mM d3-Ser. Total lipids
were extracted by the method of Bligh and Dyer (1959), and
samples were analysed with a Micromass Quattro Ultima
triple quadrupole mass spectrometer equipped with a nano-
electrospray source. [M-H] adducts of unlabelled GPSer (d3)-
labelled GPSer, unlabelled GPEtn and (d3)-labelled GPEtn
were monitored by neutral loss scanning for m/z 96 and 99
and by parent ion scanning for m/z 196 and 199 respectively.
Each spectrum encompasses at least 50 repetitive scans.
Construction of T. brucei ECT conditional gene knockout
To construct the T. brucei gene replacement cassettes, the 5′
and 3′ UTRs adjacent to the TbECT ORF were ampliﬁed from
the pCR-Blunt-II-ﬂECT construct using the primers F1 and
5′-GGATCCGTTTAAACTTACGGACCGTCAAGCTTCAAAG
GGGTAAAACCCACAGATAC-3′ (R1) for the 5′-UTR; and the
primers 5′-AAGCTTGACGGTCCGTAAGTTTAAACGGATCC
ACTTTTATCCTTCGTGAGGAAT-3′ (F2) and R2 for the 3′
UTR. The ampliﬁed products were then used in a knitting
PCR, that utilized a short linker region (underlined) containing
the restriction sites BamHI, HindIII and PmeI in order to
anneal together the 5′-to the 3′ UTR.
A HindIII restriction site internal to the sequence of the
3′-UTR was silenced by site directed mutagenesis using the
forward primer 5′-CCATCAAAAAAGAAGGAGAAGCCTTGC
ATGGATAAGTAGAG-3′, the reverse primer 5′-CTCTACTT
ATCCATGCAAGGCTTCTCCTTCTTTTTTGATGG-3′ and the
QuickChange Site Directed Mutagenesis Kit (Stratagene).
The stitched UTRs were then ligated into pGEM-5Zf(+)
(Promega) via the NotI sites and the antibiotic resistance
markers hygromycin phosphotransferase (HYG) or puromy-
cin acetyltransferase (PAC) were ligated between the BamHI
and HindIII restriction sites.
To generate the tetracycline inducible ectopic copy of the
TbECT gene, the ORF was ampliﬁed by PCR from the pCR-
Blunt-II-ﬂECT construct using Pfu polymerase and the
forward and reverse primers 5′-CCCAAGCTTGGGATG
AAACGGTCGGTGTCGAAGGT-3′ and 5′-CCTTAATTAAGG
CACCTCTCTGACATTTCTGTACA-3′. The PCR product was
then cloned into the vector pLew100, which contained a
phleomycin resistance cassette (Wirtz et al., 1999), using the
HindIII and PacI sites (underlined).
These constructs were puriﬁed using a QIAprep Miniprep
Plasmid Kit (Qiagen), linearized with NotI, precipitated with
sodium acetate/ethanol and dissolved in sterile water to a
ﬁnal concentration of 2 mg ml
-1. The DNA was then elec-
troporated into T. brucei bloodstream form cells: 3 ¥ 10
7 cells
were re-suspended in T-cell Nucleofector solution and trans-
fected using the program X-001 on an AMAXA Biosystems
nucleofector. Transfected cells were left to recover in HMI-9
medium overnight or for 6 h; a 10-fold dilution of the cells was
also applied at this stage. After recovery, drug selection was
achieved in the presence of a ﬁnal concentration of
0.1 mgm l
-1 of puromycin for cells containing the PAC gene;
2.5 mgm l
-1 of phleomycin for cells transfected with the
pLew100 construct; and 4 mgm l
-1 of hygromycyn for cells
containing the HYG gene. Before deletion of the second
TbECT allele expression of ectopic TbECT was ensured by
addition of 1 mgm l
-1 of tetracycline. This concentration was
maintained for culturing of the TbECT conditional null mutant,
whereas arrest of ECT gene expression was achieved by
washing cells three times in tetracycline-free HMI-9 prior to
culturing in tetracycline-free HMI-9.
RNA isolation and cDNA synthesis
Total RNA was isolated from bloodstream form T. brucei
using the RNeasy mini kit (Qiagen). TbECT speciﬁc cDNA
was generated and ampliﬁed using the speciﬁc forward
5′-GAGATATACATATGAAACGGTCGGTGTCGAAGG-3′ and
reverse 5′-CCGGATCCTCACACCTCTCTGACATTTCTGTA
C-3′ primers using the SuperScript III One step RT-PCR kit
with Platinum Taq (Invitrogen). As a negative control to
exclude DNAcontamination of the RNAsample, reverse tran-
scriptase was omitted from the reaction and replaced with
GoTaq polymerase (Promega). Tubulin tyrosine-ligase
(TbTTL) cDNA was also ampliﬁed using the forward and
reverse primers 5′-GGAATTCCATATGATGAGTGAGTTCC
CGTTGGTGTC-3′ and 5′-CGCGGATCCGCGTCACGTGC
TCCCGATAGGCAATTC-3′ to show equal RNA input. The
PCR products were then run on a 1% agarose gel.
Southern and Northern blotting
Southern and Northern blotting were performed essentially
as described before (Martin and Smith, 2006a), using TbECT
speciﬁc probes generated by PCR using the primers previ-
ously described for the ampliﬁcation of the ECT ORF for
ligation into pLew100.
Subcellular localization studies
Immunoﬂuorescence, subcellular fractionation and differen-
tial centrifugation were carried out on the TbECT cKO cells
grown in the presence of tetracycline as described before
(Martin and Smith, 2006b).
Mitotracker staining
Mid-log bloodstream form T. brucei parental SM cells and
TbECT cKO cells grown in the presence or absence of tet-
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in HMI-9 medium containing 50 nM Mitotracker Red CMXRos
(Molecular Probes). Cells were then harvested, washed in
HMI-9 medium and incubated for further 30 min in the
absence of Mitotracker. Cells were collected by centrifugation
(800 g, 10 min), washed in PBS and ﬁxed with 4%(w/v)
paraformaldehyde in PBS. Cells were counterstained with
4,6-diamidino-2-phenylindole (DAPI, 2 mgm l
-1), washed in
PBS, let adhere to polylysine slides and the slides mounted.
In vivo T. brucei metabolic labelling
For metabolic labelling 2 ¥ 10
7 mid-log cells were centrifuged
(800 g, 10 min) and washed in: serine free Minimal Essential
Media (MEM), for [
3H]serine and [
3H]ethanolamine labelling;
methionine free MEM, for [
35S]methionine labelling; glucose
free MEM, for [
3H]mannose labelling and MEM supplemented
with defatted BSA precoupled with [
3H]myristate for
[
3H]myristate labelling. The cells were then re-suspended in
the appropriate media at the ﬁnal concentration of 1 ¥ 10
7
cells ml
-1. Cells were labelled for 1 h at 37°C with 50 mCi ml
-1
of the relevant radiolabelled species. Two aliquots containing
each 1 ¥ 10
7 cells were then collected from each labelling
experiment by centrifugation (800 g, 10 min) and used for
lipid and protein analysis.
Lipids were extracted in chloroform:methanol:water
(10:10:3) for 1 h, the supernatant removed and the pellet
extracted with fresh 10:10:3 for 1 h. The supernatants were
pooled and dried under a stream of nitrogen prior to desalting
using butanol/water partitioning. Lipids were separated by
HPTLC using silica 60 HPTLC plates with chloroform :
methanol : water (10:10:3 v/v) as the solvent. The aqueous
phases containing the ethanolamine metabolites were dried
under a nitrogen stream and separated by HPTLC using
silica 60 HPTLC plates in a solvent system composed by
100% ethanol : 0.5% sodium chloride : 25% ammonium
hydroxide (10:10:1). Cold ethanolamine, ethanolamine-
phosphate and CDP-ethanolamine standards were run in
parallel and detected with ninhydrin. Radiolabelled species
were detected by ﬂuorography at -80°C, after spraying with
En
3hance
TM and using Kodak Biomax MS ﬁlm with an inten-
sifying screen. Proteins were separated on a 4–12% SDS-
PAGE gel and visualized by Coomassie blue staining.
Destained gel was soaked in En
3hance
TM (NEN) for 30 min,
washed with water twice, soaked in 10% glycerol and dried.
The dried gel was then exposed to Kodak Biomax MS ﬁlm for
7 days at -80°C.
Electron microscopy
For scanning electron microscopy the samples were ﬁxed
directly in HMI-9 media by adding glutaraldehyde to a ﬁnal
concentration of 2.5% (v/v) and processed as described
before (Urbaniak et al., 2006). Samples were then examined
using a Philips XL 30 environmental scanning electron micro-
scope operating at an accelerating voltage of 15 Kv.
For transmission electron microscopy cell pellets were
ﬁxed for up to 24 h with Peter’s ﬁxative (1.25% glutatalde-
hyde, 1% paraformaldehyde in 0.08 M sodium cacodylate
pH 7.2 with 0.02% calcium chloride). Samples were rinsed
twice in 0.08 M sodium cacodylate pH 7.2 then postﬁxed/
stained with 1% osmium tetraoxide (aq) for 1 h. Specimens
were then rinsed twice in distilled water before ﬁxation/
staining in 3% uranyl acetate (aq) for 16–18 h. Samples were
rinsed twice in distilled water, dehydrated through a graded
ethanol series then washed twice in propylene oxide.
Samples were then inﬁltrated with a 50% (v/v) mixture of
Durcopan resin and propylene oxide for 24 h on a rotary
mixer at room temperature. After inﬁltration for a further 24 h
in 100% Durcopan resin, samples were polymerized at 60°C
for 24 h. Sections were cut using a Leica Ultracut UCT micro-
tome, mounted on pioloform coated copper grids, post
stained with 3% uranyl acetate (aq) and Reynold’s lead
citrate and examined using a JEOL-1200 EX transmission
electron microscope operating at a accelerating voltage of
80 Kv.
Electrospray tandem mass spectrometry
Total lipids from 1 ¥ 10
8 trypanosomes were extracted by the
method of Bligh and Dyer (1959) with un-natural lipid stan-
dards added prior to lipid extraction [1 nmol of standard per
sample, with the exception of GPIno(12:0 13:0) of which only
0.2 nmol were added per sample]. Samples were analysed
with a Micromass Quattro Ultima triple quadrupole mass
spectrometer equipped with a nano-electrospray source, as
described previously (Guler et al., 2008). Each spectrum
encompasses at least 50 repetitive scans.
TbECT recombinant protein expression and puriﬁcation
The ECT ORF was PCR ampliﬁed from the pCR-Blunt-II-
ﬂECT construct with Pfu polymerase using the forward
primer 5′-GGAATTCCATATGATGAAACGGTCGGTGTCGA
AG-3′ containing a NdeI restriction site (underlined) and the
reverse primer 5′-GGATCCCCTTGAAAATACAGGTTTTCG
CCGCCGGTACCCACCTCTCTGACATTTCTGTACACATCT
GGC-3′, which contains a BamHI restriction site (underlined)
and encodes a product carrying a TEV protease cleavage site
(bold). The amplicon was puriﬁed (QIAquick PCR puriﬁcation
kit, Qiagen), subcloned into pCR-Blunt II TOPO (Invitrogen)
and sequenced. Using the NdeI and BamHI restriction sites
the putative TbECT was ligated into the expression vector
pET-20b (Novagen), generating the construct pET20b-
TbECT-TEVP-His6, which incorporates a C-terminal TEV
cleavable hexa-histidine tag when expressed.
The pET20b-TbECT-TEVP-His6 construct was transformed
in BL21(DE3) Codon plus RIL cells and clones selected on
LB-agar plates containing carbenicillin (100 mgm l
-1) and
chloramphenicol (25 mgm l
-1). Starter cultures were grown at
37°C from single colonies in 10 ml of LB medium containing
carbenicillin (50 mgm l
-1) and chloramphenicol (12.5 mgm l
-1),
for at least 5 h. The starter culture was then used to inoculate
1 l of autoinduction media (Studier, 2005) and the cells were
grown at room temperature for 24 h. Cells were harvested by
centrifugation (3500 g, 20 min, 4°C) and re-suspended in
buffer A (50 mM HEPES pH 7.5, 300 mM NaCl, 10 mM
imidazole, 2 mM b-mercaptoethanol and 5% glycerol). Cells
were lysed in the presence of Dnase I using a French
press and the lysate cleared by centrifugation (35 000 g,
30 min, 4°C).
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TM column
(GE-Healthcare) preloaded with Ni
2+. Unbound proteins were
removed by washing the column with 15 column volumes of
buffer A, while TbECT was eluted with an imidazole gradient
in the same buffer.
Fractions containing TbECT were pooled and the His-tag
was cleaved with TEV protease (1 mg of protease per
10–20 mg of protein substrate) containing an uncleavable
His-tag, while dialysing against buffer A. The cleaved TbECT
was puriﬁed from the remaining His-tagged version of
TbECT, the tag and the His-tagged TEV protease with a
second round of nickel ion affinity chromatography, as
described above. Fractions containing cleaved TbECT were
pooled, the purity of the sample was checked by SDS-PAGE,
and aliquots were snap frozen in liquid nitrogen and stored at
-80°C.
In order to assess the molecular weight and the oligomeric
state in solution of TbECT, the protein was puriﬁed as above
but glycerol, which can interfere with such analyses, was
omitted from the puriﬁcation buffers. Exact molecular weight
was assessed by MALDI time-of-ﬂight mass spectrometry.
Sedimentation velocity experiments were performed (wave-
length of 280 nm, rotor AN50-TI at 45 000 r.p.m. and 20°C),
using a Beckman Coulter XL-1 analytical ultracentrifuge. The
samples were run in 25 mM HEPES pH 7.5, 50 mM NaCl,
2 mM DTT, 2 mM MgCl2 at concentrations of 0.25, 0.5 and
0.75 mg ml
-1. Samples were centrifuged simultaneously and
A280 measurements taken at ﬁve-minute intervals for 16 h.
The resultant data were analysed using the programs
SEDFIT and SEDNTERP (Schuck, 2000; Lebowitz et al.,
2002).
Assay of TbECT activity
Ethanolamine-phosphate cytidylyltransferase activity was
measured by a malachite green colorimetric assay in 96-well
plate format using a SpectraMAX 340PC plate reader
(Molecular Devices). The assay contained 25 mM Bis-tris
propane pH 7.5, 5 mM MgCl2, 1.425 mg ml
-1 of recombinant
TbECT, 0.1 unit of inorganic pyrophosphatase (Sigma) and
varying concentrations of CTP and Etn-P, in a total volume of
50 ml. The reaction was carried out for 5 min at room tem-
perature and stopped by the addition of 100 ml of malachite
green reagent (Biomol Green), and the absorbance recorded
at 620 nm. Controls were conducted to make sure enzyme
activity and product formation displayed a linear relationship
in the time span of the assay. All enzyme assays were con-
ducted at least in triplicate. Enzyme Kinetics, SigmaPlot
(SPSS), was used to analyse and ﬁt the kinetic data. Sub-
strate recognition was investigated by substituting either
Etn-P or CTP with substrate analogues or alternative nucle-
otide phosphates.
The pH optimum of the reaction was assessed by measur-
ing TbECT activity at various pHs: Bis-Tris methane (pH 6.5,
7.0), Bis-Tris propane (pH 7.5, 8.0, 8.5) or Glycine (pH 9.0).
The production of CDP-ethanolamine by the ethanolamine-
phosphate cytidylyltransferase assay was assessed using a
modiﬁed method of Tijburg et al. (1992). Brieﬂy, 2 mg of puri-
ﬁed protein are incubated with a reaction mixture (total
volume 50 ml) of 100 mM Tris pH 8, 10 mM MgCl2,5 m M
CTP, and 4 mM Etn-P at 37°C for 20 min and quenched by
boiling at 100°C for 5 min. Substrates and products were
separated by HPTLC using silica 60 plates with 100%
ethanol : 0.5% sodium chloride : 25% ammonium hydroxide
(10:10:1, v/v) as solvent. Substrates and products were visu-
alized by spraying with ninhydrin (0.2% in water-saturated
butan-1-ol).
Cell-free system assay of GPI biosynthesis
Membranes of T. brucei wild-type and TbECT conditional null
mutants grown in the presence or absence of tetracycline for
30, 36 and 42 h were isolated and prepared as described
previously (without the addition of tunicamycin prior to lysis)
(Smith et al., 1997), snap frozen in liquid nitrogen and stored
at -80°C until required. The cell-free system assay was
carried out and visualized as described before (Smith et al.,
1997) using 1 ¥ 10
7 cell equivalents per assay, GDP-
[
3H]Mannose (0.3 mCi per 10
7 cell equivalents) with or without
1 mM PMSF.
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